LPP strapline

Multiple Sclerosis


Benefits of the contract

The LPP monitors the use of multiple sclerosis medicines, where there are price changes, or at the end of the patent, when generic versions become available. The volumes are taken from IQVIA and Define databases. The contract is owned by the Commercial Medicines Unit.


Contract description

Applicable to all London trusts providing services for multiple sclerosis. 


Contract Overview
LPP Ref: Multiple Sclerosis